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The retrovirus encoded proteinase (PR) is required for the proper maturation of viral particles into infectious virus. The PR had been considered 
highly substrate specific, cleaving exclusively the viral gag and gag-pol protein precursor. It has recently been reported, however, that cytoskeleton 
and other cellular filament proteins can be cleaved by the HIV-I PR. Here we have evidence that a cell-associated protein, the fibronectin (A-chain), 
is also cleaved in vitro specifically by this PR. The possibility of a cytotoxic role of the PR is conceivable. 
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1. INTRODUCTION 
Retrovirttses encode a proteinase necessary for the 
maturat ion process o f  infectious retrovirus particles [1]. 
This enzyme is exogenous to the cell; it is transferred 
into the host cell by retroviral infection and processes 
retroviral protein precursors. As many cellular 
proteases are capable o f  act ing catabolical ly, the ques- 
tion arose as to whether or not this viral enzyme might 
attack host cell proteins - as a side-effect and in a cyto- 
toxic way. Based on the fact that infection by oncorna  
viruses generally does not cause cytotoxic  effects but 
rather immortalizes the host cells, it was thought  that 
the viral proteinase is prevented f rom cleaving cellular 
proteins by a high substrate specificity [2-4]. Recently 
it has, however, been reported that cellular proteins can 
be cleaved, at least in vitro, by purified HIV-prote inase 
[5-8]. This tempted us to determine whether or  not cell- 
associated proteins like fibronectin [9] can serve in vitro 
as substrates for the purified HIV-1 proteinase. In this 
manuscript we demonstrate  evidence that plasma fibro- 
nectin (A-chain) is cleaved in vitro by the H IV - I  
proteinase at a site 39 kDa from the C-terminal  end. 
This cleavage site is within a domain  responsible for 
tibronectin binding to lymphocytes  and the trans- 
amidase reactive site. 
2. MATERIALS  AND METHODS 
2.1. Recombimmt protehtase 
Recombinant expression and preparation of rceon]binant HIV-I 
proteinase was as described in [10,11]. The bacterial lysates were used 
partly purified as the source ofproteolytic activity. In key experiments 
the recombinant HIV-l-protcinase was highly purified. 
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2.2. Fibrunectht ( FN) 
The haman plasma fibronectin and the antiserum to it used was 
purchased from Sigma (Munich)or highly purified fibronectin used 
in the preparation of cleavage fragments for microsequencing was 
provided by H. H6rmann and H. Richter (Max Planck Institute of 
Biochemistry. Munich). 
Microsequencing was done by Appligene (StraBbourg). 
2.3. ht vitro proteolytic assay of fibronectin 
An equivalent of about 175 ng (Fig. IA) and 50 ng (Fig. I B and C) 
of the recombinant HIV-I proteinase was incubated with about 65/.tg 
(Fig. IA). 4/.tg (Fig. I B) and I/.zg (Fig. IC) of fibronectin at 37°C in 
a PNTE lysate buffer (50 mM MES, pH 6.5/150 mM NaCI/0.05% 
"rween/I mM EDTA) for the periods of time indicated in the figure 
legends. To exclude proteolytic activities by non-aspartic proteases the 
incubation mixture contained 1/tim leupeptin, 0.1 mM EDTA. 0.2 
rnM PMSF. In a particular experiment the specific inhibitor of the 
HIV-I proteinase, EMD 57464, (E. Merck. Darmstadt) [12] was used 
to verify the specific leavage by the viral enzyme. The reaction was 
stopped by the addition of 4× concentrated lectrophoresis buffer (7% 
SDS/30% glycerol/20%,b'.mercaptoethanol/0.01% Bromphenol blue in 
90 mM Tris-HCI, pH 6.8) and boiling lot' 15 rain. The reaction 
products were separated by 10% or 7% SDS/PAGE and stained with 
Coomassie blue or. in part, inmlunoblotted on nitrocellulose filters 
and incubated with antiserum to human fibroncetin from Sigma. In 
kinetic studies (Fig. 2) the quantity of resulting cleavage product of 
the 39 kDa fragment was determined by densitometry (Elscript 400/ 
Hirschmann. Unterhaching). 
3. RESULTS AND DISCUSSION 
The in vitro incubation of  plasma fibronectin with the 
H IV - I  proteinase resulted in the cleavage of  the 240 
kDa fibronectin, yielding a polypeptide of  about 39 kDa 
and 200 kDa analysed by SDS-PAGE and Coomassie  
blue or the Western blot technique (Fig. IA, B and C). 
Often minor  amounts  slightly smaller than the 39 
kDa band could also be detected. The rate o f  cleavage 
appeared to be fast. The majority o f  the cleavage pro- 
duct was detectable after 10-15 rain o f  the reaction (Figs. 
IB and 2). In control experiments (not shown) we ex- 
c luded the possibility that nonspccil ic protcinase con- 
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Fig. 1. Cleavage of plasma-fibronectin by HIV-I proteinase yielding 
a polypeptide of about 39 kDa. Incubation of recombinant HIV-1 
proteinase (A: 175 rig; B and C: 50 ng) with plasma-fibronectin (A: 65 
/Jg; B: 4. pg; C: 1 /Jg) at 37°C in PNTE buffer containing 1 ,uM 
leupeptin, 0.1 mM EDTA, 0.2 mM PMSF to exclude proteolytic 
contaminations bynon-aspartic proteases. The reaction products were 
analysed by SDS-PAGE (A and B: I0%: C: 7%) and Coomassie blue 
(A). and in addition (B and C), by immunoblot technique using poly- 
clonal anti-fibronectin serum. (A} Coomassie blue staining: lane 1, 
incubation for 4 h; lane 2, no incubation. (B) Immunoblot: lane 1, no 
incubation; lane 2, incubation for I0 rain; lane 3, incubation for 4 h. 
(C) lmmunoblot: lane 1. no incubation; lane 2, incubation for 10 rain; 
lane 3, incubation for I h. The arrows mark the cleaved polypeptide 
bands. 
taminations from the bacterial lysate or fibronectin- 
inherent proteolytic activities were responsible for the 
cleavage observed: we incubated fibronectin with bac- 
terial lysate carrying no PR construct or incubated fi- 
bronectin alone without lysate and did not detect any 
cleavage. Further, the specific HIV-I proteinase inhibi- 
tor, EMD 57464, [12] did block the HIV proteinase 
cleavage of fibronectin indicating its specificity (not 
shown). 
The cleavage of the viral gag and gag-pol protein 
precursor by retroviral proteinase is independent of 
Ca -~+ or Mg:* ions (yon der Helm, unpublished). Also 
the fibronectin-cleavage by HIV-PR is - in contrast o 
Ca-~*.dependent fibronectin-inherent proteolytic ac- 
tivities [13,14] - independent of the presence of Ca 2.. 
The results did not allow us to decide if the A- or 
B-chain of the fibronectin or both of them were cleav- 
ed by the HIV proteinase. Thus, the cleaved fragment 
of 39 kDa was purified and the N-terminal amino 
acids microsequenced. The resulting sequence of 
EEHGFRRTTP (Fig. 3) is unique for the amino acid 
sequence of the fibronectin A-chain because the comple- 
mentary region in the B-chain is spliced out (Fig. 3) 
[15,16], The resulting cleavage site in the fibronectin, 
..QMIF/EEHG.,, is not only different from the se- 
quence pattern of the HIV-I gag-pol precursor cleavage 
sites [1], but also fi'om that of possible non-viral, cellular 
substrates [5-8]. Only the ...IF motif at the P2/PI posi- 
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tion resembles a putative consensus equence of the 
cleavage site; the EE at the new N-terminus is 
apparently different from known HIV-1 proteinase 
cleavage sites and computer predictions thereof which 
would tolerate one E in the P'2 or P3 position but not 
in P'I and P'2. 
The observed fibronectin cleavage has been carried 
out with highly purified, intact fibronectin [21]. It is 
unlikely (see Fig. IC) but not excluded that a fibro- 
nectin fragment rather than the full length A-chain was 
cleaved. This is, however, not essential in the context of 
the identification of non-viral sequences for a HIV-I 
proteinase cleavage site hitherto unknown. 
The cleavage site is located within the V segment of 
fibronectin (also called type I11 connecting segment; III 
CS). a region of alternative splicing (Fig. 3) [15,16]. 
Interestingly, the V segment contains - about 35 amino 
acids upstream of the HIV-! proteinase cleavage site - 
a cell-binding domain (CS-I) mediating cell attachment 
of B and T lymphocytes via the integrin receptor c~4/~I 
[I 7-19]. The adhesion of B lymphocytes to fibronectin 
is mediated exclusively by the interaction of ~4fll with 
this cell-adhesion site (CS-1) [19]. 
Another interesting region, the transamidase r active 
site [15,20.21], is also located closely to the HIV-I pro- 
teinase cleavage site. The sequence GQQ is likely to be 
a target site on the fibronectin molecule for the action 
of the transamidase or the transglutaminidase factor 
XIIla mediating covalent crosslinking of fibronectin 
molecules via Gln-Lys [15,22]. Presently we do not 
know whether or not the described in vitro cleavage will 
affect one or both domains because it is unknown 
whether such a cleavage occurs in vivo. If so, this would 
be further evidence for a possible cytotoxic role of  the 
HIV proteinase: although fibronectin is not an integral 
cellular or membrane protein, it offers specific binding 









I ; , I I I 
80 40 50 60 TO 
time [mini 
Fig. 2. Kinetics of the plasma-fibronectin cleavage by the HIV-I pro- 
teinase. Recombinant HIV-I proteinase (100 ng) was incubated with 
plasrna-libronectin (2 ,ug) for increasing periods of time (I-60 nfin} 
under the uo~lditions described in Fig. 1. The reaction products ,,~ere 
analysed by Western blot. The quantity of r:sulting cleavage product 
was determined by dcnsitometry of tile 39 kDa fragment in each lane 
(Els~ript 400/Hirschmann. Unterhaching). The intensity of the 39 kDa 
band is plotted ;is a function of incubation time. 
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Fig. 3. H1V-I proteinase cleavage site within the plasma-fibronectin molecule A-chain. The two chains of plasma-fibronectin are depicted. The 
N-terminal amino acid sequence EEHGFRRTTP  (underlined) of the 39 kDa peptide arising after cleavage (arrow) is in the fibroneclin A-chain. 
This sequence is located within the V segment (V). a region of  alternative splicing, which is spliced out in the B-chain. Upstream of the H1V-1 
cleavage site: a celI binding domain (CS- 1) for B- and T-lymphocytes; the sequence GQQ (underlined). a target site For the action of  a cell-associated 
transamidase of the transglutaminidase factor X l l la  mediating covalent crosslinking of  fibronectin molecules via GIn-Lys. 
sites for the cell surface mediating attachment to ex- 
tracellular structure or cell-to-cell adhesion essential for 
cellular differentiation, growth and cell/tissue organiza- 
tion. Cleavage of  the fibronectin at the indicated site 
upon HIV-I  infection might impair some or all o f  the 
mentioned functions. 
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